AllenHF, MazzoniC, HeptullaRA, MurrayMA, MillerN, KoenigsL, ReiterEO: Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab, 18:761–768, 2005.
2.
American College of Obstetricians and Gynecologists: Polycystic Ovary Syndrome. Washington, DC: American College of Obstetricians and Gynecologists; 2009. ACOG Practice Bulletin; No. 108.
3.
BhattacharyaSM, JhaA: Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS). Fertil Steril, 94:357–359, 2010.
4.
ElsenbruchS, HahnS, KowalskyD, OffnerAH, SchedlowskiM, MannK, JanssenOE: Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 88:5801–5807, 2003.
5.
HahnS, JanssenOE, TanS, PlegerK, MannK, SchedlowskiM, ElsenbruchS: Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol, 153:853–860, 2005.
6.
HimeleinMJ, ThatcherSS: Polycystic ovary syndrome and mental health: A review. Obstet Gynecol Surv, 61:723–732, 2006.
7.
LanzoE, MongeM, TrentM: Diagnosis and management of polycystic ovary syndrome in adolescent girls. Pediatr Ann, 44:e223–e230, 2015.
8.
MajewskaMD, DemirgorenS, SpivakCE, LondonED: The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res, 526:143–146, 1990.
9.
ManssonM, HolteJ, Landin-WilhelmsenK, DahlgrenE, JohanssonA, LandenM: Women with polycystic ovary syndrome are often depressed or anxious—A case control study. Psychoneuroendocrinology, 33:1132–1138, 2008.
PaulS, SimonD, EndrassT, KathmannN: Altered emotion regulation in obsessive-compulsive disorder as evidenced by the late positive potential. Psychol Med, 46:137–147, 2016.
12.
RasgonNL, RaoRC, HwangS, AltshulerLL, ElmanS, Zuckerbrow-MillerJ, KorenmanSG: Depression in women with polycystic ovary syndrome: Clinical and biochemical correlates. J Affect Disord, 74:299–304, 2003.
13.
RiceT, SherL: Neuroendocrinology of emotion regulation and suicide risk in adolescents. Neuropsychiatry, 3:551–554, 2013.
14.
RichterMA, de JesusDR, HoppenbrouwersS, DaigleM, DeluceJ, RavindranLN, DaskalakisZJ: Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder. Neuropsychopharmacology, 37:1144–1151, 2012.
15.
WalitzaS, MelfsenS, JansT, ZellmannH, WewetzerC, WarnkeA: Obsessive-compulsive disorder in children and adolescents. Dtsch Arztebl Int, 108:173–179, 2011.
16.
WeinerCL, PrimeauM, EhrmannDA: Androgens and mood dysfunction in women: Comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med, 66:356–362, 2004.
